| Sequent Scientific Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 512529 |
NSE Symbol : SEQUENT |
P/E(TTM) : 361.15 |
|
ISIN Demat : INE807F01027 |
Div & Yield% : - |
EPS(TTM) : 0.48 |
|
Book Value(₹) : 43.56 |
Market Cap(₹Cr) : 4,326.50 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 57.67 | 36.77 | 42.21 | 49.12 | 40.42 | 46.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 57.67 | 36.77 | 42.21 | 49.12 | 40.42 | 46.60 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 10.84 | 12.98 | 13.44 | 9.87 | 9.70 | 8.01 |
| Total Income | 68.51 | 49.75 | 55.65 | 58.99 | 50.12 | 54.61 |
| Total Expenditure | 59.65 | 42.53 | 46.36 | 56.82 | 55.74 | 52.64 |
| PBIDT | 8.86 | 7.22 | 9.29 | 2.17 | -5.62 | 1.97 |
| Interest | 0.81 | 1.01 | 1.15 | 1.21 | 0.98 | 0.87 |
| PBDT | 8.05 | 6.21 | 8.14 | 0.96 | -6.60 | 1.10 |
| Depreciation | 2.00 | 2.11 | 2.05 | 2.35 | 2.43 | 2.33 |
| Tax | 0.97 | 0.00 | 0.46 | 1.50 | -1.50 | 0.78 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.58 | 0.34 | 1.05 | -1.98 | -0.73 | -0.36 |
| Reported Profit After Tax | 4.50 | 3.76 | 4.58 | -0.92 | -6.80 | -1.65 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -6.25 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 4.50 | 3.76 | 4.58 | -0.92 | -0.55 | -1.65 |
| EPS (Unit Curr.) | 0.18 | 0.15 | 0.18 | -0.04 | -0.27 | -0.07 |
| EPS (Adj) (Unit Curr.) | 0.18 | 0.15 | 0.18 | -0.04 | -0.27 | -0.07 |
| Calculated EPS (Unit Curr.) | 0.18 | 0.15 | 0.18 | -0.04 | -0.27 | -0.07 |
| Calculated EPS (Adj) (Unit Curr.) | 0.18 | 0.15 | 0.18 | -0.04 | -0.27 | -0.07 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.72 | 0.60 | 0.73 | -0.15 | -1.09 | -0.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.72 | 0.60 | 0.73 | -0.15 | -1.09 | -0.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 49.90 | 49.89 | 49.89 | 49.89 | 49.89 | 49.89 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 15.36 | 19.64 | 22.01 | 4.42 | -13.90 | 4.23 |
| PBDTM(%) | 13.96 | 16.89 | 19.28 | 1.95 | -16.33 | 2.36 |
| PATM(%) | 7.80 | 10.23 | 10.85 | -1.87 | -16.82 | -3.54 |